Kenneth A. Mace
Treasurer and Chief Financial Officer at Alzheon.
- Framingham, MA
- Alzheon
Raised on Alzheon filings
$126.3M
of $150M offered across 1 Form D filing
- Form D filings
- 1
- Teammates
- 12
- Last filing
- Feb 10, 2025
Company
Oral Alzheimer's drug targeting amyloid oligomers
- Investors
- 76
- Still open
- $23.7M
Alzheon filings
| Filed | Security | Sold of offered | Filing |
|---|---|---|---|
| Feb 10, 2025 | Equity | $126.3M/ $150M | Form D/A |
- EquityFiled Feb 10, 2025Form D/A$126.3M/ $150M
Works with
Martin Tolar, M.D., Ph.D.President and Chief Executive Officer, Form D signerForm D signerMuneer SatterDirectorAidan Power, MRCPsychChief Development OfficerChristopher Noel DunnDirectorDiane K. Jorkasky, M.D.DirectorGlenn E. PaulyChief Commercial OfficerNeil W. FlanzraichDirectorAdem AlbayrakChief Data OfficerGino SantiniDirectorJohn Hey, Ph.D.Chief Scientific OfficerJordan HellerDirectorSusan Abushakra, M.D.Chief Medical Officer
